Fresenius Medical Care Stock - analyst consensus and chart view
Published on 06/18/2026 at 18:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSEdited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 16:19 UTC. Details in the imprint.
Fresenius Medical Care (DE0005785802) remains without a fresh ad-hoc release or major newswire headline today, leaving the market to trade mainly on existing expectations. With no new hook from the company or regulators, the focus turns to the current analyst consensus and the technical picture of the stock.
All news and data on Fresenius Medical Care stock
Key figures, news and regulatory filings on Fresenius Medical Care stock can be followed centrally on the ad hoc news topic page and on the company's investor-relations site.
What analysts currently expect
Analyst data compiled by specialized portals shows that the market remains cautiously constructive on Fresenius Medical Care, with a mix of Buy, Hold and Sell ratings and an overall Hold tilt. The consensus 12-month price target sits moderately above the current share price level, indicating limited upside in the base case.
Several large investment banks have adjusted their models over recent quarters after the group restructured its legal form and simplified reporting. Many analysts highlight sensitivity to reimbursement trends, wage costs and interest rates as key drivers for the medium-term earnings profile.
Chart picture and key levels
On the chart, Fresenius Medical Care shares trade not far from their 200-day moving average, which acts as an important orientation mark for many technically oriented investors. The longer-term trend remains mixed after the pronounced volatility of recent years.
Shorter-term indicators such as relative strength indexes and trading volumes point to a rather balanced supply-demand situation. Large trend impulses would likely require a new fundamental trigger, for example an earnings surprise or a material change in guidance.
How the company makes its money
Fresenius Medical Care is a global dialysis specialist that earns most of its revenue from treating patients with chronic kidney failure in its own clinics and from selling dialysis machines, dialyzers and related disposables. The company also offers related services such as care coordination in selected markets.
Where the stock trades today
The shares of Fresenius Medical Care (DE0005785802) trade on Xetra at EUR 51.20 as of 06/18/2026, 15:45 CET.
Key facts on Fresenius Medical Care stock
- Company: Fresenius Medical Care AG
- ISIN: DE0005785802
- WKN: 578580
- Ticker: FME
- Venue: Xetra
- Price (as of 06/18/2026, 15:45 CET): 51.20 EUR
- Market cap: 15,800,000,000 EUR (as of 06/18/2026)
- Sector / Industry: Health Care / Health Care Providers & Services
- Index membership: DAX
- Next earnings date: 08/01/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
